Brief: Livanova Announces Core-Vns 24-Month Data Show Adjunctive Vns Therapy Is Associated With Substantial Reductions In Generalized Tonic-Clonic Seizures In People With Drug-Resistant Epilepsy

Livanova

05/06/2025 13:04

June 5 (Reuters) - LivaNova PLC LIVN.O:

LIVANOVA ANNOUNCES CORE-VNS 24-MONTH DATA SHOW ADJUNCTIVE VNS THERAPY IS ASSOCIATED WITH SUBSTANTIAL REDUCTIONS IN GENERALIZED TONIC-CLONIC SEIZURES IN PEOPLE WITH DRUG-RESISTANT EPILEPSY

LIVANOVA PLC - 77% MEDIAN SEIZURE REDUCTION, 43% SEIZURE FREEDOM AT 24 MONTHS

LIVANOVA PLC - 52% MEDIAN SEIZURE REDUCTION AT THREE MONTHS

Source text: ID:nBw8SmGbla

Further company coverage: LIVN.O

 ((Reuters.Briefs@thomsonreuters.com;))